{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-16T04:34:17.399604+00:00","company":{"ticker":"BHIC","cik":1784440,"company_name":"BioScience Health Innovations, Inc."},"pagination":{"limit":100,"returned":6,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","counterparties":{"ma_counterparty":[{"display_name":"Best Labs, Inc.","detail":"acquisition","count":1,"first_seen":"2024-06-25T23:59:59+00:00","last_seen":"2024-06-25T23:59:59+00:00","evidence_fact_ids":[124487]}]},"facts":[{"fact_type":"governance_change","fact_key":"3860980dbb9bf3c6cf959ec2556d64479a36ff90","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2025-10-16T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2025-09-10","item_codes_triggered":["5.03"],"summary_text":"Amended Restated Certificate of Incorporation to effect a 4-for-1 reverse stock split, effective September 10, 2025."},"claim":"BioScience Health Innovations, Inc.: Amended Restated Certificate of Incorporation to effect a 4-for-1 reverse stock split, effective September 10, 2025 (effective 2025-09-10).","evidence_excerpt":"On September 10, 2025, BioScience Health Innovations, Inc. (the “Company”) amended its Restated Certificate of Incorporation (the “Certificate of Incorporation”), to effect a reverse split of the Company’s common stock on the basis that 4 (four) such shares of common stock shall become 1 (one) share of common stock.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001185185-25-001456","anchor_url":"https://secwatch.observer/filing/0001185185-25-001456#claim-3860980dbb9bf3c6cf959ec2556d64479a36ff90","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518525001456/0001185185-25-001456-index.htm"},{"fact_type":"ma_transaction","fact_key":"4f00d8a3ee69d7ec3637208e5e3b630aa2577a4d","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2024-06-25T23:59:59+00:00","payload":{"action":"acquisition","closing_date":"2023-03-10","consideration_text":"34,371,100 shares of the Company’s common stock, representing approximately 85.39% of the issued and outstanding shares","counterparty":"Best Labs, Inc.","effective_date":"2023-03-10","item_codes_triggered":["2.01"]},"claim":"BioScience Health Innovations, Inc. completed an acquisition involving Best Labs, Inc. for 34,371,100 shares of the Company’s common stock, representing approximately 85.39% of the issued and outstanding shares (closed 2023-03-10).","evidence_excerpt":"2023 (the “ Closing ”). As a result of the Exchange Agreement Best became the wholly-owned subsidiary of the Company. Upon the Closing, the Company issued the Best shareholders 34,371,100 shares of the Company’s common stock, representing approximately 85.39% of the issued and outstanding shares of the Company’s common stock following Closing, in exchange for all","confidence":0.98,"filing_url":"https://secwatch.observer/filing/0001185185-24-000654","anchor_url":"https://secwatch.observer/filing/0001185185-24-000654#claim-4f00d8a3ee69d7ec3637208e5e3b630aa2577a4d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518524000654/0001185185-24-000654-index.htm"},{"fact_type":"executive_change","fact_key":"706edba3cf","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2024-06-25T23:59:59+00:00","payload":{"action":"resigned","action_category":"departure","departure_tone":"routine","effective_date":null,"interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":"Darren Lopez","successor_named":true},"claim":"Justin Earl resigned as Chief Executive Officer at BioScience Health Innovations, Inc..","evidence_excerpt":"Justin Earl tendered his resignation as the sole officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-24-000654","anchor_url":"https://secwatch.observer/filing/0001185185-24-000654#claim-706edba3cf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518524000654/0001185185-24-000654-index.htm"},{"fact_type":"executive_change","fact_key":"857994cd78","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2024-06-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"John Chymboryk was appointed as Director at BioScience Health Innovations, Inc..","evidence_excerpt":"Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-24-000654","anchor_url":"https://secwatch.observer/filing/0001185185-24-000654#claim-857994cd78","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518524000654/0001185185-24-000654-index.htm"},{"fact_type":"executive_change","fact_key":"35e00cd76a","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2024-06-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Darren Lopez was appointed as Director at BioScience Health Innovations, Inc..","evidence_excerpt":"Darren Lopez and John Chymboryk were appointed to serve on the Board of Directors with Justin Earl.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-24-000654","anchor_url":"https://secwatch.observer/filing/0001185185-24-000654#claim-35e00cd76a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518524000654/0001185185-24-000654-index.htm"},{"fact_type":"executive_change","fact_key":"bb00913206","cik":1784440,"ticker":"BHIC","company_name":"BioScience Health Innovations, Inc.","filed_at":"2024-06-25T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Darren Lopez was appointed as Chief Executive Officer at BioScience Health Innovations, Inc..","evidence_excerpt":"Darren López was appointed as the Chief Executive Officer of the Company.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001185185-24-000654","anchor_url":"https://secwatch.observer/filing/0001185185-24-000654#claim-bb00913206","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1784440/000118518524000654/0001185185-24-000654-index.htm"}]}